Get the Stockscreener App
0.34
6.70%
-0.0244
After Hours:
.36
0.02
+5.88%
Oncolytics Biotech Inc Stock (ONCY) Forecast
The Oncolytics Biotech Inc (ONCY) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.7599, representing a +417.63% increase from the current price of $0.34. The highest analyst price target is $2.2983, and the lowest is $1.2216.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ONCY Price Target
Average 2.5917
(+662.27% Upside)
Is Oncolytics Biotech Inc (ONCY) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 23.20 | Buy |
| STOCH(9,6) | 9.5108 | Buy |
| STOCHRSI(14) | 13.20 | Buy |
| MACD(12,26) | -0.052 | Sell |
| ADX(14) | 39.46 | Sell |
| William %R | -99.50 | Buy |
| CCI(14) | -96.27 | Neutral |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4064
Sell
|
0.406
Sell
|
| MA20 |
0.4668
Sell
|
0.4499
Sell
|
| MA50 |
0.5283
Sell
|
0.5268
Sell
|
| MA100 |
0.635
Sell
|
0.6257
Sell
|
| MA200 |
0.8209
Sell
|
0.7555
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ONCY could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on ONCY, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 23.2 indicates that ONCY is oversold. This indicates that ONCY price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 9.5108 indicates that ONCY is oversold. This indicates that ONCY price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 13.2 indicates that ONCY is oversold. This suggests that ONCY price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 39.46 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -96.27 indicates that ONCY is still oversold but not to an extreme extent.
Long-term ONCY price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Oncolytics Biotech Inc financial reports and earnings history, Oncolytics Biotech Inc (ONCY) stock could reach $0.6312 by 2030, $0.2162 by 2040 and $0.9796 by 2050. See the projected annual prices until 2050 of the Oncolytics Biotech Inc stock below:
- Oncolytics Biotech Inc (ONCY) is expected to reach an average price of $0.7811 in 2035, with a high prediction of $0.9161 and a low estimate of $0.4278. This indicates an $129.74% rise from the last recorded price of $0.34.
- Oncolytics Biotech Inc (ONCY) stock is projected to chart a bullish course in 2040, with an average price target of $0.0563, representing an $-83.45% surge from its current level. The forecast ranges from a conservative $0.2862 to a sky-high $0.2162.
- Our analysts predict Oncolytics Biotech Inc (ONCY) to jump 109.39% by 2045, soaring from $0.732 to an average price of $0.7119, potentially reaching $0.6519. While $0.732 is the low estimate, the potential upside is significant.
- Oncolytics Biotech Inc (ONCY) stock is expected to climb by 2050, reaching an average of $1.0154, a $198.64% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.9796 and $0.9879, respectively, highlighting the market's uncertainty.
Oncolytics Biotech Inc Stock (ONCY) Year by Year Forecast
Oncolytics Biotech Inc Stock (ONCY) Price Forecast for 2025
Oncolytics Biotech Inc Stock (ONCY) is expected to reach an average price of $2.8545 in 2025, with a high prediction of $5.3899 and a low estimate of $0.3191. This indicates an +739.55% rise from the last recorded price of $0.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $1.3716 | $1.2216 | $2.2983 | +303.42% |
| August, 2025 | $1.305 | $1.2233 | $1.5375 | +283.81% |
| September, 2025 | $1.2883 | $1.2658 | $1.6366 | +278.92% |
| October, 2025 | $1.0325 | $0.9225 | $1.3591 | +203.67% |
| November, 2025 | $1.0958 | $0.9543 | $1.3242 | +222.31% |
| December, 2025 | $1.50 | $1.0867 | $1.8491 | +341.18% |
Oncolytics Biotech Inc Stock (ONCY) Price Forecast for 2026
The predicted value for Oncolytics Biotech Inc (ONCY) in 2026 is set at an average of $2.8163. Estimates vary from a peak of $4.2609 to a trough of $1.3717, indicating an +728.33% surge from the present price of $0.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.1834 | $1.3717 | $2.2834 | +542.17% |
| February, 2026 | $1.7367 | $1.7059 | $3.6059 | +410.80% |
| March, 2026 | $2.1701 | $1.6375 | $2.3901 | +538.25% |
| April, 2026 | $2.8142 | $1.7417 | $4.1242 | +727.72% |
| May, 2026 | $2.4776 | $1.8259 | $3.4151 | +628.70% |
| June, 2026 | $3.4409 | $2.3984 | $4.2609 | +912.04% |
| July, 2026 | $2.0751 | $2.0171 | $3.5018 | +510.33% |
| August, 2026 | $2.4085 | $2.0159 | $2.6476 | +608.37% |
| September, 2026 | $2.0526 | $1.8926 | $2.4401 | +503.72% |
| October, 2026 | $1.676 | $1.546 | $2.0635 | +392.94% |
| November, 2026 | $1.7593 | $1.3777 | $1.8185 | +417.45% |
| December, 2026 | $1.5335 | $1.3718 | $1.7802 | +351.03% |
Oncolytics Biotech Inc Stock (ONCY) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Oncolytics Biotech Inc (ONCY) is $1.0647, with a high forecast of $1.8379 and a low forecast of $0.2916. This indicates an +213.15% increase from the last price of $0.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.7169 | $1.3252 | $1.8379 | +404.96% |
| February, 2027 | $1.2002 | $1.1502 | $1.7477 | +253.00% |
| March, 2027 | $0.9544 | $0.9144 | $1.351 | +180.70% |
| April, 2027 | $1.0877 | $0.7177 | $1.1177 | +219.92% |
| May, 2027 | $1.2911 | $1.0386 | $1.5086 | +279.73% |
| June, 2027 | $0.9953 | $0.9653 | $1.5519 | +192.72% |
| July, 2027 | $1.0586 | $0.9269 | $1.1469 | +211.35% |
| August, 2027 | $0.8319 | $0.8219 | $1.1603 | +144.69% |
| September, 2027 | $0.6061 | $0.5061 | $0.9336 | +78.27% |
| October, 2027 | $0.4693 | $0.2916 | $0.6872 | +38.02% |
| November, 2027 | $0.5028 | $0.4407 | $0.5411 | +47.89% |
| December, 2027 | $0.837 | $0.4536 | $0.877 | +146.17% |
Oncolytics Biotech Inc Stock (ONCY) Price Forecast for 2028
In 2028, Oncolytics Biotech Inc (ONCY) is projected to reach an average price of $1.7771, with a high projection of $2.9338 and a low estimate of $0.6204. This indicates an +422.69% rise from the last price of $0.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.8203 | $0.6287 | $1.0187 | +141.28% |
| February, 2028 | $0.7337 | $0.6637 | $0.962 | +115.79% |
| March, 2028 | $0.7679 | $0.6554 | $0.837 | +125.84% |
| April, 2028 | $1.0812 | $0.7387 | $1.4995 | +218.00% |
| May, 2028 | $1.2054 | $1.037 | $1.7929 | +254.53% |
| June, 2028 | $1.4287 | $0.9362 | $1.5187 | +320.22% |
| July, 2028 | $1.1221 | $1.0821 | $1.4895 | +230.02% |
| August, 2028 | $0.7663 | $0.7563 | $1.3529 | +125.37% |
| September, 2028 | $0.6796 | $0.6496 | $1.0071 | +99.89% |
| October, 2028 | $1.133 | $0.6204 | $1.313 | +233.22% |
| November, 2028 | $1.2571 | $1.0846 | $1.7355 | +269.75% |
| December, 2028 | $2.1405 | $1.058 | $2.9338 | +529.55% |
Oncolytics Biotech Inc Stock (ONCY) Price Forecast for 2029
The 2029 price forecast for Oncolytics Biotech Inc Stock (ONCY) is $1.6833 on average, with a high prediction of $2.9122 and a low estimate of $0.4544. This represents an +395.08% increase from the previous price of $0.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.0647 | $1.7947 | $2.9122 | +507.25% |
| February, 2029 | $1.898 | $1.4573 | $2.1655 | +458.24% |
| March, 2029 | $1.7014 | $1.6488 | $1.9705 | +400.40% |
| April, 2029 | $1.4147 | $1.3647 | $1.853 | +316.09% |
| May, 2029 | $1.0089 | $0.8689 | $1.4755 | +196.73% |
| June, 2029 | $0.9822 | $0.9097 | $1.3114 | +188.89% |
| July, 2029 | $0.9156 | $0.7406 | $0.9931 | +169.29% |
| August, 2029 | $0.7598 | $0.7231 | $0.9614 | +123.46% |
| September, 2029 | $0.56 | $0.4544 | $0.7656 | +64.70% |
| October, 2029 | $0.5773 | $0.4611 | $0.7548 | +69.79% |
| November, 2029 | $0.6406 | $0.5781 | $0.8689 | +88.42% |
| December, 2029 | $0.4581 | $0.4562 | $0.7331 | +34.74% |
Oncolytics Biotech Inc Stock (ONCY) Price Forecast for 2030
Oncolytics Biotech Inc Stock (ONCY) is expected to reach an average price of $2.3906 in 2030, with a high forecast of $4.7598 and a low forecast of $0.0215. This signifies an +603.13% surge from the last price of $0.34.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.3435 | $0.2788 | $0.6312 | +1.02% |
| February, 2030 | $0.3314 | $0.2636 | $0.5352 | -2.54% |
| March, 2030 | $0.1321 | $0.0363 | $0.3829 | -61.16% |
| April, 2030 | $0.6806 | $0.4503 | $0.6634 | +100.17% |
| May, 2030 | $0.698 | $0.658 | $0.647 | +105.30% |
| June, 2030 | $0.712 | $0.8203 | $0.752 | +109.42% |
| July, 2030 | $0.2476 | $0.197 | $0.1947 | -27.19% |
| August, 2030 | $0.3547 | $0.1453 | $0.7347 | +4.34% |
| September, 2030 | $2.6714 | $0.3862 | $4.7598 | +685.71% |
| October, 2030 | $1.3553 | $1.1314 | $2.8431 | +298.62% |
| November, 2030 | $0.1315 | $0.0435 | $1.6048 | -61.33% |
| December, 2030 | $0.2008 | $0.0215 | $0.6598 | -40.95% |
1.89%
3.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):